0
     

Increased Health Disorders Boosts the Women’s Health Diagnostics Market

Posted in Healthcare Services by Adolf on Jun 6,2022 349

The widespread infection that was termed as a pandemic soon enough by World Health Organization, has already claimed millions of lives worldwide. The recovery rate from the viral infection has improved in the past months, although dangers of after-effects of the infection, vaccination and pre vaccination concerns for CRP (c-reaction protein) still looms. Moreover, a part of population already suffering from kidney and liver disorders and related diseases are expected to go through series of health tests and get clearance from doctors and health advisors for vaccinations and treatments.

Currently, the market is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe. In the past decade, the demand for various health diagnostic tests has increased significantly across the globe.

 The women’s health diagnostics market is projected to reach US$ 36.6 billion by 2025 from US$ 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period. The increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centres are also expected to support the growth of this market during the forecast period. However, the high cost of diagnostic devices, tests, and procedures; shortage of skilled laboratory technicians; and insufficient reimbursements for diagnostic tests are expected to restrain this market's growth to a certain extent.

Based on application, the women’s health diagnostics market is divided into nine segments—osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, and ultrasound tests. The breast cancer testing segment accounted for the larger market share in 2019. The large share of this segment can be attributed to the increasing incidence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques, such as ABUS.

Based on end users, the women’s health diagnostics market is segmented into hospitals & clinics, diagnostic & imaging centres, and home care settings. The home care settings segment is expected to witness the highest growth during the forecast period. The increasing advantages of using self-testing kits will continue to drive market growth. Patient self-testing enables patients to better manage their diseases by utilizing home/self-testing kits. Technological advancements have made many self-testing kits available for various conditions, such as pregnancy and ovulation.

In 2019, North America accounted for the largest share of the women’s health diagnostics market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the increasing prevalence of cancer among women, the growing focus of manufacturers of women’s health diagnostic products on expanding their presence in this region, and the increasing demand for fertility testing monitors. In addition, the rising acceptance of POC diagnostics and PST practices is also expected to drive the growth of this regional segment during the forecast period.

The key players operating in the women’s health diagnostics market include Quest Diagnostics Incorporated (US), Hologic, Inc. (US), Siemens AG (Germany), PerkinElmer, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), General Electric Company (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), bioMérieux SA (France), Koninklijke Philips N.V. (Netherlands), Guided Therapeutics, Inc. (US), SuperSonic Imagine (France), FUJIFILM Holdings Corporation (Japan), DIALAB GmbH (Austria), Carestream Health, Inc. (US), MedGyn Products, Inc. (US), Cook Medical, Inc. (US), Osteometer MediTech, Inc. (Denmark), and NeuroLogica Corporation (US). New players entering the market may form partnerships with other players or the end users of the industry for a consistent inflow of the product.

Besides, under the healthcare market research report category, the study analyses the women’s health diagnostics market and aims at estimating the market size and future growth potential of this market based on various segments such as application type, end user, and region. It will also enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

Furthermore, the study provides insights into the comprehensive information on product portfolios offered by the top players in the global market, detailed insights on upcoming trends and product launches, exhaustive information about new products or product enhancements, growing geographies, recent developments and investments, in-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global women’s health diagnostics market.


Comment / Reply From